መነሻ › አሠሪዎች › AbbVie Inc. › Architect, Technology II
Architect, Technology II በAbbVie Inc.፡ የH-1B ደመወዞች
6 የሥራ ሁኔታ ማመልከቻዎች ለAbbVie Inc. በArchitect, Technology II የሥራ መደብ። መካከለኛ የቀረበ መሠረታዊ ደመወዝ $165,000፤ መካከለኛ ግማሽ $159,000–$168,000።
ማመልከቻዎች (LCAs)6
መካከለኛ የሚቀርብ ደመወዝ$165,000
የደመወዞች መካከለኛ ግማሽ$159,000–$168,000
ከ10ኛ እስከ 90ኛ ፐርሰንታይል$156,500–$171,000
በፊስካል ዓመት
| የፋይናንስ ዓመት | LCAs | መካከለኛ ደመወዝ |
|---|---|---|
| FY2023 | 2 | $156,500 |
| FY2024 | 2 | $165,000 |
| FY2026 | 2 | $171,000 |
ማመልከቻዎች
| መሠረታዊ ደመወዝ | አድራሻ | የቀረበበት | የመጀመሪያ ቀን | ሁኔታ |
|---|---|---|---|---|
| $173,000–$193,000 ደረጃ III | Mettawa, IL | 27 ፌብሩ 2026 | 6 ማርች 2026 | የተረጋገጠ |
| $169,000–$189,000 ደረጃ IV | Waukegan, IL | 17 ኖቬም 2025 | 25 ኖቬም 2025 | የተረጋገጠ |
| $165,000–$185,000 ደረጃ IV | Mettawa, IL | 16 ፌብሩ 2024 | 27 ፌብሩ 2024 | የተረጋገጠ |
| $165,000–$185,000 ደረጃ IV | Mettawa, IL | 12 ጃንዩ 2024 | 24 ጃንዩ 2024 | የተረጋገጠ |
| $156,000–$176,000 ደረጃ II | Waukegan, IL | 26 ጁን 2023 | 6 ጁላይ 2023 | የተረጋገጠ |
| $157,000–$177,000 ደረጃ IV | Mettawa, IL | 20 ጁን 2023 | 28 ጁን 2023 | የተረጋገጠ |
ሌሎች ሥራዎች በAbbVie Inc.
- Senior Statistician$131,918
- Manager, Statistics$147,000
- Senior Scientist I$120,000
- Senior Scientist II$145,000
- Associate Business Systems Consultant$129,212
- Senior Engineer, Technology I$148,804
- Senior Clinical Pharmacologist$135,000
- Senior Statistical Analyst$131,000
- Senior Statistician, Research$136,822
- Senior Data Engineer$150,000
- Senior Manager, Statistics$156,500
- Associate Director, Clinical Pharmacology$155,500
- Senior Research Statistician$131,500
- Manager, Statistical Programming$148,000
- Business Systems Consultant$145,237
- Data Engineer$106,000
- Director, Innovation$220,000
- Associate Director, Innovation$195,000
- Associate Director, Statistics$180,000
- Senior Scientist I, Chemistry$122,548
- Pharmacometrician$149,350
ደመወዞች በእያንዳንዱ ማመልከቻ ላይ በተገለጸው ደመወዝ ዝቅተኛ ጫፍ ሲሆኑ ወደ ዓመታዊ መጠን ተቀይረዋል፤ ስታቲስቲክሶች የተረጋገጡ ሙሉ ጊዜ ማመልከቻዎችን ብቻ ይጠቀማሉ። LCA የቪዛ ማረጋገጫ አይደለም፤ አንድ LCA ለብዙ ቦታዎች ሊሸፍን ይችላል። ምንጭ፡ የአሜሪካ የሥራ ሚኒስቴር፣ OFLC LCA መረጃ ማሳያ መረጃ፣ የፋይናንስ ዓመታት 2023–2026 (የቅርብ ጊዜ ውሳኔ 30 ጁን 2026)።